Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,2.1246703346739984e-05,9.369381042559553,100.80806400719575,"['RPL41', 'RPL23', 'RPL23A', 'RPS20', 'RPL39', 'RPS24', 'RPS12']",0.0018059697844728987,0,0,7
2,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.0005697104551942183,22.073064340239913,164.894229143965,"['ANGPT2', 'FLNA', 'NR2C2']",0.02421269434575428,0,0,3
3,Ebola Virus Pathway on Host WP4217,0.002655905465206776,5.6521739130434785,33.52287188346386,"['CTSL', 'FLNA', 'MFGE8', 'ACTG1', 'KPNA1']",0.07525065484752531,0,0,5
4,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.019306486084457813,5.601526717557252,22.110985802521917,"['PRKN', 'PSMD6', 'FBXW7']",0.4102628292947285,0,0,3
5,SARS-CoV-2 and COVID-19 Pathway WP4846,0.04816431895709728,25.383458646616543,76.9915025998712,['CTSL'],0.6471374346509611,0,0,1
6,Translation Factors WP107,0.08353815961050261,4.339458413926499,10.772496134551313,"['EIF1AY', 'EIF3D']",0.6471374346509611,0,0,2
7,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.08503216143662533,12.68796992481203,31.272365861724936,['CDO1'],0.6471374346509611,0,0,1
8,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.09245005901435062,4.078181818181818,9.710504417355411,"['CTNNA2', 'ACTG1']",0.6471374346509611,0,0,2
9,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.09402544792503366,11.27736006683375,26.661819762101256,['PHEX'],0.6471374346509611,0,0,1
10,Leptin Insulin Overlap WP3935,0.10293099263132237,10.148872180451129,23.075455051500096,['DGKZ'],0.6471374346509611,0,0,1
11,Pathways affected in adenoid cystic carcinoma WP3651,0.10473649014096782,3.7749719416386083,8.517498262596114,"['FBXW7', 'UHRF1']",0.6471374346509611,0,0,2
12,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.12048224665424477,8.456140350877194,17.895331266167503,['MYRIP'],0.6471374346509611,0,0,1
13,Cysteine and methionine catabolism WP4504,0.12912963069198832,7.805089647194911,15.976538417511254,['CDO1'],0.6471374346509611,0,0,1
14,Mitochondrial complex III assembly WP4921,0.13769262255726045,7.247046186895811,14.368946400758453,['UQCRB'],0.6471374346509611,0,0,1
15,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.1461720396387773,6.763408521303258,13.00583842933991,['EIF3D'],0.6471374346509611,0,0,1
16,Focal Adhesion WP306,0.17093071962978756,2.155574669390388,3.8078160853085983,"['FLNA', 'DOCK1', 'ACTG1']",0.6471374346509611,0,0,3
17,7-oxo-C and 7beta-HC pathways WP5064,0.17927003545054795,5.337950138504155,9.175199821602106,['ACOT9'],0.6471374346509611,0,0,1
18,Striated Muscle Contraction Pathway WP383,0.17927003545054795,5.337950138504155,9.175199821602106,['ACTG1'],0.6471374346509611,0,0,1
19,Glycerolipids and Glycerophospholipids WP4722,0.17927003545054795,5.337950138504155,9.175199821602106,['DGKZ'],0.6471374346509611,0,0,1
20,Androgen receptor signaling pathway WP138,0.18195776828523846,2.642857142857143,4.503377461796089,"['FLNA', 'NR2C2']",0.6471374346509611,0,0,2
21,SARS-CoV-2 mitochondrial interactions WP5038,0.1873435678131062,5.070676691729323,8.492425540858983,['CTSL'],0.6471374346509611,0,0,1
22,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.19533826762708445,4.828857858933047,7.885633617457899,['MFGE8'],0.6471374346509611,0,0,1
23,Oxysterols derived from cholesterol WP4545,0.22654391165319196,4.055037593984962,6.020986656365285,['ACOT9'],0.6471374346509611,0,0,1
24,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.22654391165319196,4.055037593984962,6.020986656365285,['ANGPT2'],0.6471374346509611,0,0,1
25,Thermogenesis WP4321,0.22855225617884073,2.258922558922559,3.3341480170625593,"['SMARCC2', 'ACTG1']",0.6471374346509611,0,0,2
26,Intraflagellar transport proteins binding to dynein WP4532,0.23415576287140732,3.8987854251012144,5.660134772068719,['DYNC1LI2'],0.6471374346509611,0,0,1
27,Nuclear receptors WP170,0.24169325668645586,3.7541074909495964,5.331155081870967,['NR2C2'],0.6471374346509611,0,0,1
28,Prion disease pathway WP3995,0.24915711412321115,3.619763694951665,5.030282809521413,['PDIA3'],0.6471374346509611,0,0,1
29,Endoderm differentiation WP2853,0.2539970325619358,2.0948141205873165,2.8708017605048894,"['ATP8B2', 'NAA15']",0.6471374346509611,0,0,2
30,Tumor suppressor activity of SMARCB1 WP4204,0.26386676895672245,3.3779448621553883,4.500472983284056,['SMARCC2'],0.6471374346509611,0,0,1
31,Signaling of Hepatocyte Growth Factor Receptor WP313,0.27111397382044367,3.268736357021586,4.266406924038734,['DOCK1'],0.6471374346509611,0,0,1
32,Parkinson's disease pathway WP2371,0.2782903574053599,3.1663533834586466,4.050051770133591,['PRKN'],0.6471374346509611,0,0,1
33,Fas ligand pathway and stress induction of heat shock proteins WP314,0.29243340169132803,2.979655019902698,3.663540448433824,['ACTG1'],0.6471374346509611,0,0,1
34,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.29243340169132803,2.979655019902698,3.663540448433824,['ACTG1'],0.6471374346509611,0,0,1
35,Common Pathways Underlying Drug Addiction WP2636,0.3131337678626711,2.7374517374517375,3.1785231186144887,['ACTG1'],0.6471374346509611,0,0,1
36,Myometrial relaxation and contraction pathways WP289,0.3194399489506193,1.7645586297760212,2.013689562193986,"['DGKZ', 'ACTG1']",0.6471374346509611,0,0,2
37,Netrin-UNC5B signaling pathway WP4747,0.31989941978163905,2.665215670755837,3.037675951448894,['PPP2R1B'],0.6471374346509611,0,0,1
38,Metabolic reprogramming in colon cancer WP4290,0.31989941978163905,2.665215670755837,3.037675951448894,['PYCR2'],0.6471374346509611,0,0,1
39,Glycogen Synthesis and Degradation WP500,0.31989941978163905,2.665215670755837,3.037675951448894,['PPP2R1B'],0.6471374346509611,0,0,1
40,Regulation of Actin Cytoskeleton WP51,0.3230492694368787,1.749216300940439,1.9765277121729286,"['DOCK1', 'ACTG1']",0.6471374346509611,0,0,2
41,ATM Signaling Network in Development and Disease  WP3878,0.3332329169625505,2.531578947368421,2.781986492117931,['RNF40'],0.6471374346509611,0,0,1
42,Modulators of TCR signaling and T cell activation WP5072,0.3332329169625505,2.531578947368421,2.781986492117931,['DGKZ'],0.6471374346509611,0,0,1
43,Pathogenic Escherichia coli infection WP2272,0.3398020399844512,2.469649734091326,2.665720329460282,['ACTG1'],0.6471374346509611,0,0,1
44,Phosphodiesterases in neuronal function WP4222,0.3398020399844512,2.469649734091326,2.665720329460282,['PDE8A'],0.6471374346509611,0,0,1
45,One-carbon metabolism and related pathways WP3940,0.346306920814409,2.410669530970283,2.556345911643567,['CDO1'],0.6471374346509611,0,0,1
46,Nucleotide Excision Repair WP4753,0.3527481830572309,2.3544325931106838,2.453320737524493,['RAD23B'],0.6471374346509611,0,0,1
47,IL-4 signaling pathway WP395,0.36544231603818983,2.249456975772765,2.264408743565719,['FLNA'],0.6471374346509611,0,0,1
48,G1 to S cell cycle control WP45,0.36544231603818983,2.249456975772765,2.264408743565719,['TFDP2'],0.6471374346509611,0,0,1
49,Rett syndrome causing genes WP4312,0.37788930837947393,2.1534154535274355,2.0956047787569356,['IMPDH2'],0.6528367589635107,0,0,1
50,Glucocorticoid Receptor Pathway WP2880,0.38402162291971215,2.1083959899749374,2.0178539145087178,['MFGE8'],0.6528367589635107,0,0,1
51,Notch Signaling Pathway Netpath WP61,0.4020608837740981,1.9839304142709715,1.8076616681596718,['FBXW7'],0.6604432023671523,0,0,1
52,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.4079566668059918,1.9456333140543667,1.7444437762915477,['CTSL'],0.6604432023671523,0,0,1
53,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.4137947458524719,1.9087813874308412,1.684280467421054,['ANGPT2'],0.6604432023671523,0,0,1
54,3q29 copy number variation syndrome WP4906,0.4195756815038379,1.8732943469785575,1.6269774219439377,['FBXW7'],0.6604432023671523,0,0,1
55,Endometrial cancer WP4155,0.4421390128922653,1.74358309567021,1.4229921065585736,['CTNNA2'],0.6711038588543312,0,0,1
56,Proteasome Degradation WP183,0.4421390128922653,1.74358309567021,1.4229921065585736,['PSMD6'],0.6711038588543312,0,0,1
57,Prolactin Signaling Pathway WP2037,0.4638315106631109,1.6306087800145526,1.252688968978238,['FLNA'],0.6793618198226149,0,0,1
58,"GPCRs, Class A Rhodopsin-like WP455",0.46912250578441966,1.6046067549826948,1.2145129541934758,['RRH'],0.6793618198226149,0,0,1
59,Retinoblastoma gene in cancer WP2446,0.47954951987478694,1.5550028918449972,1.1427842456330524,['TFDP2'],0.6793618198226149,0,0,1
60,DNA IR-damage and cellular response via ATR WP4016,0.47954951987478694,1.5550028918449972,1.1427842456330524,['SMARCC2'],0.6793618198226149,0,0,1
61,Joubert Syndrome WP4656,0.5047362036363977,1.4433941997851771,0.9868765516138533,['FLNA'],0.6987280126325317,0,0,1
62,Pyrimidine metabolism WP4022,0.5192635453852438,1.3837676382737667,0.9068434456908037,['PNPT1'],0.6987280126325317,0,0,1
63,Vitamin D Receptor Pathway WP2877,0.5333678492393694,1.328848436881678,0.8352396377518239,['TRAK1'],0.6987280126325317,0,0,1
64,Wnt signaling pathway and pluripotency WP399,0.5333678492393694,1.328848436881678,0.8352396377518239,['PPP2R1B'],0.6987280126325317,0,0,1
65,Integrin-mediated Cell Adhesion WP185,0.5425417509852599,1.294582610372084,0.7916246261804291,['DOCK1'],0.6987280126325317,0,0,1
66,G Protein Signaling Pathways WP35,0.5425417509852599,1.294582610372084,0.7916246261804291,['PDE8A'],0.6987280126325317,0,0,1
67,22q11.2 copy number variation syndrome WP4657,0.5515366145579761,1.2620300751879698,0.7509672753149679,['PRKN'],0.6997106304093728,0,0,1
68,Regulation of toll-like receptor signaling pathway WP1449,0.5603559082841497,1.2310654685494222,0.713012371772418,['ZMYND11'],0.7004448853551871,0,0,1
69,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.5732630786450617,1.1873507297655905,0.6606544638030455,['UQCRB'],0.7061936476062354,0,0,1
70,Cell cycle WP179,0.5979597401649426,1.1085681236057177,0.570061038645553,['TFDP2'],0.7163886160253962,0,0,1
71,Ciliary landscape WP4352,0.5983951969153309,0.998049804980498,0.5125024461921938,"['EFHC2', 'CDR2']",0.7163886160253962,0,0,2
72,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.6142370979578331,0.9688228438228438,0.472179328541406,"['ANGPT2', 'PPP2R1B']",0.7251410184224418,0,0,2
73,PI3K-Akt signaling pathway WP4172,0.6245329465990416,0.9502572898799314,0.44733475386019855,"['ANGPT2', 'PPP2R1B']",0.7271958967249114,0,0,2
74,Mesodermal commitment pathway WP2857,0.6431763478163187,0.9785385794583547,0.43186462979283796,['ATP8B2'],0.7387836427619877,0,0,1
75,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.6570968989438579,0.9416766214601925,0.3954324105605293,['NR2C2'],0.7424679167568771,0,0,1
76,DNA Repair Pathways Full Network WP4946,0.6638536667473254,0.9242601917638132,0.37866342540639064,['RAD23B'],0.7424679167568771,0,0,1
77,Ectoderm Differentiation WP2858,0.6864782658945453,0.8680321493388644,0.3265369533395239,['CTNNA2'],0.7578006831303422,0,0,1
78,VEGFA-VEGFR2 Signaling Pathway WP3888,0.7103286437718567,0.8177066047129107,0.2796781763993436,"['ACOT9', 'EIF3D', 'ACTG1']",0.764450452915824,0,0,3
79,mRNA Processing WP411,0.7104892444747071,0.8115449915110357,0.27738727068509555,['HNRNPR'],0.764450452915824,0,0,1
80,Nonalcoholic fatty liver disease WP4396,0.7245597429454496,0.779798333041907,0.251244051266346,['UQCRB'],0.7698447268795402,0,0,1
81,Circadian rhythm related genes WP3594,0.7580459903752581,0.707720004235942,0.19604638310960235,['CIPC'],0.7954803602703325,0,0,1
82,Ciliopathies WP4803,0.7874878416670098,0.6477322338103323,0.15474798990520186,['CCNQ'],0.8162983724597053,0,0,1
83,IL-18 signaling pathway WP4754,0.8393683086246608,0.5474752454907761,0.09586602711074313,['FBXW7'],0.8595940510011587,0,0,1
84,MAPK Signaling Pathway WP382,0.8561171569366322,0.5160065111231688,0.08016060354900101,['FLNA'],0.8645098817439151,0,0,1
85,Nuclear Receptors Meta-Pathway WP2882,0.8645098817439151,0.5003007518796992,0.0728400588987979,['MFGE8'],0.8645098817439151,0,0,1
